Mulai
ChristopherCarrollSmith

Pharmaceuticals showing strength this earnings season

Pembelian
Direxion Daily S&P Biotech Bull 3X Shares (AMEX:LABU)  
ChristopherCarrollSmith  
AMEX:LABU   Direxion Daily S&P Biotech Bull 3X Shares
Fundamental Analysis Earnings pharmaceuticals
7
0
fundamental earnings pharmaceuticals
It's been a banner quarter for large-cap pharmaceutical companies. We've had earnings beats and guidance upgrades from GlaxoSmithKline, Biogen, Bristol-Myers Squibb, Merck, Celgene, and Procter & Gamble. More earnings beats may be coming, with Amgen reporting today after market and Amarin tomorrow. In my opinion, the whole sector is set to surge, and the leveraged Direxion Biotech Bull ETF could be a very strong play this quarter if you can find a good entry point.

Ide yang Berhubungan

ChristopherCarrollSmith
LABU - watch the volume and trend line
Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.